Review slides Flashcards

1
Q

Surveillance. Think what 2 things?

A

Surveillance​

Prevalence

Incidence rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prevalence is a _ of a population at a given point in time

Incidence is a _ of a population at a given point in time

A

Prevalence is a measure of the state of a population at a given point in time

Incidence is a measure of events of a population at a given point in time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cumulative incidence is the _ of new cases that develop in a population _

equation?

A

Cumulative incidence is the proportion (risk) of new cases that develop in a population over time

CI = Pr(New Disease) = risk of disease =​ (# new cases)/ pop at risk….. over time t

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Incidence rate is the instantaneous or _

It is not a _ or _

equation?

A

Incidence rate is the instantaneous or average rate of disease occurrence

It is not a probability or proportion

IR=Rate of disease= (# cases)/(Persons at risk * time) or (sum of person time from follow up)

  • person time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RR equation

A

RR= P(D+, E+)/ P(D+/E-).. over time t

RR= CI exposed/ CI unexposed.. over time t

CI exposed= (cases w/ exposure)/(person w/ exposure at risk)

CI unexposed=(cases w/o exposure)/(persons w/o exposure at risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk difference eqt

A

I1-I0

Incidence among exposed- incidence among unexposed

the exposure is associated with a _% absolute increase in risk, compared to the unexposed group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Incidence rate ratio eqt

A

IRR= (rate of disease in exposed)/(rate of disease in unexposed)

IRR= (incidence rate in exposed)/(incidence rate unexposed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Odds ratio or exposure OR

A

[(E+,D+)/(E-,D+)]/[(E+,D-)/(E-,D-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Components of an Outbreak Investigation

1) Verify the _ and confirm the _
2) Define a _ and conduct _ _
3) Tabulate and orient _: _, _, and _
4) Take immediate _ _
5) Formulate and test _
6) Plan and execute _ _
7) Implement and evaluate _ _
8) Communicate _

A

Components of an Outbreak Investigation

1) Verify the diagnosis and confirm the outbreak
2) Define a case and conduct case finding
3) Tabulate and orient data: time, place, and person
4) Take immediate control measures
5) Formulate and test hypothesis
6) Plan and execute additional studies
7) Implement and evaluate control measures
8) Communicate findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Steps to determine if an outbreak is real

1) verify _
2) define a _
3) ID & count _
4) _ vs _
5) rule out other _

A

Steps to determine if an outbreak is real

1) verify diagnosis
2) define a case
3) ID & count cases
4) Observed vs expected
5) rule out other reasons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypothesis generating vs. hypothesis testing

A

Hypothesis generating:

  • Attempt to identify most likely exposures

- Cases only, limited number

- Open-ended questions

Hypothesis testing:

  • Focus on most likely cause or causes
  • Include comparison group
  • Closed-ended question
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Attack rate= _

Eqt?

A

Attack rate= CI

(New cases)/(Population at risk)…. over time t

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Secondary attack rate

Secondary Attack Rate = P(D+|_)

Secondary Attack Rate = P(D+|_)

A

Secondary attack rate

Secondary Attack Rate = P(D+|Contact with a known case)

Secondary Attack Rate = P(D+|Exposure to a known case)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe common source point epidemic

A

Sharp slope w/ gradual downslope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe Common Source Point with Secondary Transmission (Mixed)

A

Initial point source with subsequent person-to-person transmission

May have either:
a bimodal appearance Or
a prolonged downslope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe Common Source Continuous Epidemic

A

Rise sharply, as with point source

Plateau reached and sustained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe a propagative epidemic

A

Encompasses several generations of the agent

Begins with single case or small number of cases

Downslope related to exhaustion of susceptible hosts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What outbreak?

A

Common Source Continuous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What outbreak?

A

Common Source Point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What outbreak?

A

Propagative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What outbreak?

A

Common Source Intermittent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Simple Structure of Four Study Designs

A

A) Pros Cohort

B) Retro Cohort

C) Case Control

D) Cross-sectional

23
Q

Best use for cohort study (2)

A

short latent period

well-defined pop at risk

24
Q

Best uses for case-control

A

Long latent period

unclear pop at risk

common exposure

25
best use cross-sectional
initial evaluation- Used to take out population that isnt at risk anymore
26
Study design: **Cross Sectional** Measure of frequency: Measure of association:
Study design: **Cross Sectional** Measure of frequency: **Prevalence** Measure of association: **Prevalance ratio**
27
Study design: **Case Control** Measure of frequency Measure of association
Study design: **Case Control** Measure of frequency: **None** Measure of association: **Odds ratio**
28
Study design: **Retrospective cohort** Measure of frequency: **Cumulative incidence** Measure of association other consideration
Study design: **Retrospective cohort** Measure of frequency: **Cumulative incidence** Measure of association: **Risk ratio** other consideration: **Use with minimal loss to follow-up**
29
Study design: **Retrospective cohort** Measure of frequency: **Incidence rate** Measure of association other consideration
Study design: **Retrospective cohort** Measure of frequency: **Incidence rate** Measure of association: **Incidence rate ratio** other consideration: **Use with loss to follow-up; recurrent disease**
30
Study design: **Prospective cohort** Measure of frequency: **Cumulative incidence** Measure of association: other consideration
Study design: **Prospective cohort** Measure of frequency: **Cumulative incidence** Measure of association: **Risk ratio** other consideration: **Use with minimal loss to follow-up**
31
Study design: **Prospective cohort** Measure of frequency: **Incidence rate** Measure of association other consideration
Study design: **Prospective cohort** Measure of frequency: **Incidence rate** Measure of association: **Incidence rate ratio** other consideration: **Use with loss to follow-up; recurrent disease**
32
Epi causal triad
Host Agent Environment
33
Epi causal triad: AGENT (3)
Infectivity; pathogenesis; virulence;
34
Infectivity ## Footnote The characteristic of the agent that reflects the ability to **\_**, **\_**, and\_**.**
Infectivity ## Footnote The characteristic of the agent that reflects the ability to **enter**, **survive**, and **multiply** i**n the host.**
35
Pathogenicity Property of an organism that determines the **\_** to which overt disease is **\_** in **\_**
Pathogenicity Property of an organism that determines the **extent** to which overt disease is **produced** in **an infected population**
36
Virulence: A measure of the **\_** caused by an organism
Virulence: A measure of the **severity of the disease** caused by an organism
37
Infectivity eqt
people infected/ people exposed
38
pathogenicity eqt
clinical cases/ people infected
39
virulence eqts
severe cases/ clinical cases severe cases/ people infected clinical cases/ people infected
40
incubation period
time between infection and clinical symptoms
41
Latent period
time between infection and infectious period
42
serial interval
time between clinical symptoms in 1\* and 2\*
43
what comes first, infectious period or clinical symptoms?
infectious period
44
Reproductive (reproduction) number (R) average number of **\_** per **I**
Reproductive (reproduction) number (R) average number of **successful transmissions** per **infectious person** Secondary cases/ primary cases
45
R: When will an epidemic stop?
So with R \< 1, the epidemic is not sustainable
46
When should R be at a maximum? R0: Basic reproductive number
If everyone is susceptible (s = 1), R should be at its maximum. R0 = average number of secondary cases caused by a single, typical person in a **completely susceptible population**
47
Rn : Net (effective) reproductive number If the infection is initiated in a population with \<100% susceptibility, the net R (Rn) will be less than **\_** Similarly, as the number of susceptible persons in a population is not stable (e.g. disease causes immunity), **\_**
Rn : Net (effective) reproductive number If the infection is initiated in a population with \<100% susceptibility, the net R (Rn) will be less than **R0** Similarly, as the number of susceptible persons in a population is not stable (e.g. disease causes immunity), **R will change over time​**
48
Rn: Function of R0 and proportion susceptible eqt?
Rn =R0\*s Where s = proportion of the population that is susceptible to the infection
49
Herd immunity threshold (HIT) eqt If the population can attain a level of immunization (or immunity) \> HIT, what will happen?
HIT= 1–s =1–1/R0 HIT=(R0 –1)/R0 If the population can attain a level of immunization (or immunity) \> HIT, what will happen? **The epidemic should end**
50
Components of R0
R0 = pcD transmission probability (p); ``` contact rates (c); length of infectious period (D); ```
51
Rn = R0\_= pcD\_
Rn = R0s = pcDs transmission probability (p); ``` contact rates (c); length of infectious period (D); ``` proportion of susceptibles (s)
52
What does the relationship R = pcDs suggest about potential targets / mechanisms for control strategies?
Reduce transmission probability (p); early treatment Decrease contact rates (c); stay home!!! (quarantine) Reduce length of infectious period (D); treatment Reduce proportion of susceptibles (s): flu shots (immunization)
53
Cancer Clusters difficulties
Clusters sometimes result from confounders Difficult to establish a cause-and-effect relationship between disease and exposure extra Often fail to come to a satisfactory conclusion. Unable to confirm a geographical or temporal excess in the number of cases A cluster may be a collection of several diseases Establishing source of cluster very difficult
54
Cancer cluster Preliminary Evaluation: SIR
Standardized incidence ratio Number of observed/ expected Non-infectious disease